Carcinoma of lung
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Carcinoma of lung
|
0.600 |
CausalMutation
|
disease |
CGI |
|
|
|
Lung Neoplasms
|
0.500 |
CausalMutation
|
group |
CGI |
|
|
|
Lung Neoplasms
|
0.500 |
Biomarker
|
group |
CTD_human |
|
|
|
Malignant neoplasm of lung
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
Malignant neoplasm of lung
|
0.500 |
CausalMutation
|
disease |
CGI |
|
|
|
Breast Carcinoma
|
0.460 |
Biomarker
|
disease |
CTD_human |
|
|
|
Breast Carcinoma
|
0.460 |
Biomarker
|
disease |
HPO |
|
|
|
Embryonal Rhabdomyosarcoma
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Malignant neoplasm of breast
|
0.360 |
Biomarker
|
disease |
CTD_human |
|
|
|
Mammary Neoplasms
|
0.320 |
Biomarker
|
group |
CTD_human |
|
|
|
Rhabdomyosarcoma
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Breast Cancer, Familial
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Mammary Neoplasms, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Rhabdomyosarcoma 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Mammary Carcinoma, Human
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Bronchioloalveolar Adenocarcinoma
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Somatic mutation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
RHABDOMYOSARCOMA, SOMATIC
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Squamous cell carcinoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Comparison of the frequency distributions of the CYP2D6 PM, HET and EM genotypes (G-->A transition at intron 3/exon 4 and base pair deletion in exon 5) revealed no significant differences between the menorrhagia and SCC groups.
|
7917923 |
1994 |
Breast Carcinoma
|
0.460 |
Biomarker
|
disease |
BEFREE |
We were able to show that HET is localized in the nuclear matrix in various breast cancer cell lines.
|
9328833 |
1997 |
Malignant neoplasm of breast
|
0.360 |
Biomarker
|
disease |
BEFREE |
We were able to show that HET is localized in the nuclear matrix in various breast cancer cell lines.
|
9328833 |
1997 |
Breast Carcinoma
|
0.460 |
GeneticVariation
|
disease |
BEFREE |
Because this region frequently is altered in neoplasms and in the genetic disease Beckwith-Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith-Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T.
|
9520460 |
1998 |
Embryonal Rhabdomyosarcoma
|
0.400 |
GeneticVariation
|
disease |
ORPHANET |
Transcriptional map of 170-kb region at chromosome 11p15.5: identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples.
|
9520460 |
1998 |
Malignant neoplasm of breast
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Because this region frequently is altered in neoplasms and in the genetic disease Beckwith-Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith-Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T.
|
9520460 |
1998 |